| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/11/2002 | US6402791 Hair dyes |
| 06/06/2002 | WO2002044302A1 Novel red fluorescent material and organic electroluminescent device containing same |
| 06/06/2002 | WO2002044171A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
| 06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044142A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/06/2002 | WO2002043732A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002020483A8 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001068614A3 5-substituted arylpyrimidines |
| 06/06/2002 | WO2001044207B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/06/2002 | US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered |
| 06/06/2002 | US20020068755 Antitumor agents. |
| 06/06/2002 | US20020068753 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/06/2002 | US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
| 06/06/2002 | DE10060412A1 DELTA1-Pyrroline DELTA1-pyrrolines |
| 06/06/2002 | CA2689915A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2625277A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211251A1 Chromone derivatives, process for the preparation of the same and uses thereof |
| 06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
| 06/05/2002 | EP1211246A1 Pyrimidine derivatives and herbicides containing the same |
| 06/05/2002 | EP1211244A2 4,5-substitued imidazolyl compounds for the treatment of inflammation |
| 06/05/2002 | EP1210598A1 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
| 06/05/2002 | EP1169309A4 Propynyl uracils |
| 06/05/2002 | EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors |
| 06/05/2002 | EP0891336B1 Substituted 1-methyl-3-benzyluracils |
| 06/05/2002 | CN1352643A Novel method for producing doxazosin mesylate in a crystalline modification designated as form A |
| 06/05/2002 | CN1352642A Farnesyl protein transferase inhibitors |
| 06/05/2002 | CN1352641A Isonipecotamides for the treatment of integrin mediated disorders |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
| 06/04/2002 | US6399779 Aryl borates |
| 06/04/2002 | US6399775 Methods for the preparation of polymorphs of doxazosin mesylate |
| 06/04/2002 | US6399771 Cyclic imines as pesticides |
| 06/04/2002 | US6399657 Antiinflammatory agents |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399633 Flavopiridol; low dosage; vascular lesions after ballon or stent |
| 06/04/2002 | US6399619 Prevention and treatment of aids and viral infection by hiv |
| 06/04/2002 | US6399611 2-(4-ethoxycarbonylaminobenzyl)-6-(3,4 -dimethoxyphenyl)-2,3,4, 5-tetrahydropyridazin-3-one or alternately benzyl substituted compounds; phosphodiesterase iv and tumour necrosis factor inhibitors |
| 06/04/2002 | US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399602 Anticancer agents |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 06/04/2002 | CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 06/04/2002 | CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same |
| 05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers |
| 05/30/2002 | WO2002042277A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 05/30/2002 | WO2002041843A2 Antiinflammation agents |
| 05/30/2002 | WO2002041835A2 Estrogen receptor modulators |
| 05/30/2002 | WO2002041834A2 Atorvastatin hemi-calcium form vii |
| 05/30/2002 | WO2002004444A3 Heterocycle carboxamides as antiviral agents |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001085709A3 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them |
| 05/30/2002 | US20020065419 Cyclobutenedione compounds |
| 05/30/2002 | US20020065418 Viral polymerase inhibitors |
| 05/30/2002 | US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | US20020065305 As antitumor agent |
| 05/30/2002 | US20020065304 As antitumor agent |
| 05/30/2002 | US20020065303 Bivalent phenylene inhibitors of factor Xa |
| 05/30/2002 | US20020065287 Methods for the preparation of polymorphs of doxazosin mesylate |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 05/30/2002 | US20020065270 For use in therapy of inflammatory diseases such as, for example, rheumatoid arthritis |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | CA2428459A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/29/2002 | EP1208098A2 Substituted heterocyclyl-2h-chromenes |
| 05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208085A2 Benzanilides as potassium channel openers |
| 05/29/2002 | EP1070076A4 Chiral separations of pyrimidines |